Cellectar Biosciences To Present at SeeThru Equity and Dawson James Investor Conferences
MADISON, Wis., Oct. 11, 2016 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB) (the “company”), an oncology-focused, clinical stage biotechnology company, today announces that Jim Caruso, president and CEO of Cellectar, will be presenting at …